Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019

ROYAL LANCASTER LONDON

  • Advocating European Excellence in Advanced Therapies

    Advocating European Excellence in Advanced Therapies

    17th - 18th September 2019

    The Royal Lancaster London

  • 18 Countries  |  350 Attendees  |  90 Speakers  |  32 Exhibitors

    18 Countries | 350 Attendees | 90 Speakers | 32 Exhibitors

Welcome to Phacilitate Leaders Europe 2019

Phacilitate Leaders Europe 2019 is focused on promoting European excellence in cell and gene therapy by putting global challenges in a regional context. 

The event is tailored to a European audience looking to commercialise ATMPs, as well as a global audience interested in entering the European market. 



Show starts in...

 


 

Opportunity!
At Phacilitate we are dedicated to highlighting the opportunities provided by the European market for Advanced Therapies

Opportunity!

Who should attend?
The entire ecosystem of Advanced Therapies will be meeting in London in September. Make sure this is the event for you!

Who should attend?

Register!
Get your name on the attendee list before everyone else does! 

Register!

Investor Portal
Phacilitate Leaders Europe is the only educational cell and gene therapy specific event which uncovers investment opportunities in Europe

Investor Portal

Sponsorship
Find out who is sponsoring the event this year, how your company might benefit from exhibiting, and what packages are available

Sponsorship

Phacilitate:Exchange
Join the largest online Advanced Therapies community, and benefit from an exclusive 10% off Phacilitate events!

Phacilitate:Exchange

Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
    Celyad
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd